Dr. Venkata Sandeep Akshintala, MD

Dr. Akshintala practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Akshintala's NPI, 1528486594, was assigned on April 7, 2014. Dr. Akshintala holds Maryland license D91127.

Dr. Akshintala's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Akshintala's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Akshintala is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Akshintala to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akshintala practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Akshintala's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Akshintala is licensed in Maryland.

CMS data shows 487 Medicare services from Dr. Akshintala across 15 procedure codes in 2024, for 421 Medicare patients. Medicare paid $81,048 for them.

CMS counts 421 Medicare patients who saw Dr. Akshintala in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akshintala's median patient age at 73, with 56% women.

In 2024, Dr. Akshintala wrote 267 Medicare Part D claims for 105 patients. 79% of them were for generic drugs. CMS names the drug for 163 of them, across 8 drugs with 11 or more claims each, at $65,074 in total drug cost. In 2023, CMS named 172 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Akshintala for performance year 2024, reported as part of a group. CMS lists Dr. Akshintala as offering telehealth. CMS counts 470 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Akshintala, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 90 papers to Dr. Akshintala, published from 2013 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde and Pancreatitis, Chronic. Dr. Akshintala has published most often in Pancreas. Dr. Akshintala's most frequent co-authors are Vikesh K. Singh, MD, MS, Mouen A. Khashab, MD and Samuel Y. Han, MD.

Dmand AI links Dr. Akshintala to 2 clinical trials. Conditions studied include Autoimmune Pancreatitis and Pancreatitis, Chronic. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 82 general payments to Dr. Akshintala from 14 drug and device companies from 2017 to 2025. Grants make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $50,456. It also lists 1 research payment totaling $1,150 in 2022.